evaluate the food technology company chinova bioworks on glp-1 diet Drugs Are Rewriting Rules of Live webinar to discuss GLP-1

Potential Downsides and Unknowns Long-term safety : Retatrutide is still in trials, so long-term LDL and cardiovascular outcomes arent confirmed

It works by burning fat for energy, which improves physical endurance and aids weight loss

Qu, Q., Zeng, F., Liu, X., Wang, Q., & Deng, F

New FDA policy on compounding GLP-1 drugs New FDA policy on compounding GLP-1 drugs On April 24, 2025, FDA announced that licensed pharmacies and physicians can no longer compound semaglutide (a GLP-1 drug used in Ozempic & Wegovy) and outsourcing facilities must stop production by May 22, 2025

Mergoni G, Ergun S, Vescovi P, Mete O, Tanyeri H, Meleti M